| 000 | 00891 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250513134313.0 | ||
| 264 | 0 | _c19980422 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a1081-4442 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFefer, A | |
| 245 | 0 | 0 |
_aInterleukin-2 in the treatment of hematologic malignancies. _h[electronic resource] |
| 260 |
_bThe cancer journal from Scientific American _cDec 1997 |
||
| 300 |
_aS35-6 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aInterleukin-2 _xtherapeutic use |
| 773 | 0 |
_tThe cancer journal from Scientific American _gvol. 3 Suppl 1 _gp. S35-6 |
|
| 999 |
_c9426481 _d9426481 |
||